Amerikanische Gesellschaft für Hirudotherapie

Overcoming prolonged ischemia in total scalp avulsion after industrial accident

Case report published in Am J Case Rep (2025)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportKlinische StudienNgo Duc et al. · The American journal of case reports, 2025

Abstract

BACKGROUND Total scalp avulsion is a rare but severe injury, commonly associated with industrial accidents. Historically, treatment options have been limited, with poor outcomes in terms of tissue survival and functional recovery, especially in prolonged ischemic time, which can lead to a cascade of events, including thrombosis and necrosis. Microsurgical replantation, however, has proven to be a more effective technique, offering improved results in tissue viability and patient recovery. This case report highlights the success of microsurgical intervention in treating scalp avulsion injuries, even under challenging circumstances, such as prolonged ischemic time. CASE REPORT A 28-year-old woman had a total scalp avulsion when her hair became caught in machinery at a fiber tractor factory. She was admitted to the hospital 4 h after injury, and the avulsed scalp was successfully replanted 7 h after initial trauma. The surgical team performed bilateral anastomosis of the superficial temporal arteries and veins. Despite prolonged ischemic time, most scalp tissue survived, with only a small area of partial necrosis developing in the right occipital region. This was later treated with debridement and split-skin grafting. Follow-up revealed promising results, including substantial hair regrowth and recovery of sensation in the affected areas. CONCLUSIONS This case illustrates the effectiveness of microsurgical replantation for treating total scalp avulsion, even in cases of extended ischemic time. Prompt surgical intervention, with appropriate postoperative care, is critical to achieving favorable outcomes. Preventive measures, such as the use of protective helmets in occupational environments, are essential in reducing the risk of such injuries.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleCase Reports
Indexed MeSH termsHumansFemaleScalpAdultReplantationAccidents, OccupationalMicrosurgeryIschemia

Zusammenfassung

Total scalp avulsion case overcoming prolonged ischemia after industrial accident via microsurgical replantation.

Warum dies für die Hirudotherapie relevant ist

This case report described the successful microsurgical replantation of a totally avulsed scalp in a 28-year-old woman following an industrial accident, achieved despite a prolonged ischemia time. The study highlights the effectiveness of prompt bilateral superficial temporal artery and vein anastomosis, alongside postoperative care, in achieving tissue viability and substantial hair regrowth. While scalp replantation and severe avulsion injuries are clinical scenarios where hirudotherapy is sometimes utilized to salvage compromised tissue or manage venous congestion, this specific abstract does not mention leeches. As a result, its relevance to the American Society of Hirudotherapy is entirely indirect, focusing solely on the surgical and microsurgical management of the injury.

Zitation

Overcoming prolonged ischemia in total scalp avulsion after industrial accident.

Ngo Duc et al. · The American journal of case reports, 2025

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.